CEBP CTRC-AACR San Antonio Breast Cancer Symposium 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, S. C.
Right arrow Articles by Klein-Szanto, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, S. C.
Right arrow Articles by Klein-Szanto, A. J.

Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 7 597-603, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity

SC Liu, ER Sauter, ML Clapper, RS Feldman, L Levin, SY Chen, TJ Yen, E Ross, PF Engstrom and AJ Klein-Szanto
Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

The expression of several markers of epithelial cell proliferation was analyzed to establish baseline data for future chemoprevention studies of oral premalignant lesions. Punch biopsies (n = 60) from three different sites of oral mucosa (bucca, lateral tongue, and the floor of the mouth) were obtained from 20 normal donors of both sexes. After formaldehyde fixation and paraffin embedding, immunohistochemistry was used to detect the proliferation markers Mib-1, cyclin D1, and centromere-associated protein CENP-F. Analysis of sections stained for the three markers showed similar patterns, i.e., a low labeling index (LI) in the basal layer and a high LI in the parabasal layer at all three intraoral sites. No proliferative activity was seen above the parabasal layer (superficial layer). All sites showed similar Mib-1 LI values for the proliferative markers. The tongue epithelium exhibited higher parabasal LIs of cyclin D1 and CENP-F than did the other two sites. No significant differences were detected between smokers and nonsmokers. The data from normal mucosa were compared with those from low (n = 30)- and high (n = 17)-grade dysplastic leukoplakias. The Mib-1 LI showed a very significant change, with a 9-fold increase in the basal layer LI in dysplastic leukoplakias. Cyclin D1 and CENP-F showed similar trends with increments of up to 7-fold in the basal layer of high-grade dysplasia. Although the proliferative activity of the parabasal layer was similar in normal and leukoplakic epithelia, the superficial layer showed a significant increment in proliferative activity mainly in high-grade leukoplakia. These studies suggest that proliferation markers in the basal and superficial cells of premalignant lesions may serve as surrogate end point biomarkers for chemoprevention trials.


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
A. Tyagi, K. Raina, R. P. Singh, M. Gu, C. Agarwal, G. Harrison, L. M. Glode, and R. Agarwal
Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice
Mol. Cancer Ther., December 1, 2007; 6(12): 3248 - 3255.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. McGregor, A. Muntoni, J. Fleming, J. Brown, D. H. Felix, D. G. MacDonald, E. K. Parkinson, and P. R. Harrison
Molecular Changes Associated with Oral Dysplasia Progression and Acquisition of Immortality: Potential for Its Reversal by 5-Azacytidine
Cancer Res., August 15, 2002; 62(16): 4757 - 4766.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
K. S. J. Elenitoba-Johnson, S. D. Bohling, S. D. Jenson, Z. Lin, K. A. Monnin, and M. S. Lim
Fluorescence PCR Quantification of Cyclin D1 Expression
J. Mol. Diagn., May 1, 2002; 4(2): 90 - 96.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-C. Liu, S. Y. Zhang, J. S. Babb, J. A. Ridge, and A. J. P. Klein-Szanto
Image Cytometry of Cyclin D1: A Prognostic Marker for Head and Neck Squamous Cell Carcinomas
Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 455 - 459.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
E. I. Salim, H. Wanibuchi, K. Morimura, S. Kim, Y. Yano, S. Yamamoto, and S. Fukushima
Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine
Carcinogenesis, February 1, 2000; 21(2): 195 - 203.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. R. Sauter, M. Herlyn, S.-C. Liu, S. Litwin, and J. A. Ridge
Prolonged Response to Antisense Cyclin D1 in a Human Squamous Cancer Xenograft Model
Clin. Cancer Res., February 1, 2000; 6(2): 654 - 660.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. L. Goodwin, L. M. Pabon-Pena, G. C. Foster, and D. Bader
The Cloning and Analysis of LEK1 Identifies Variations in the LEK/Centromere Protein F/Mitosin Gene Family
J. Biol. Chem., June 25, 1999; 274(26): 18597 - 18604.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.